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Arterial Stiffness Increases With Deteriorating
Glucose Tolerance Status
The Hoorn Study
Ronald M.A. Henry, MD; Piet J. Kostense, PhD; Annemieke M.W. Spijkerman, PhD;
Jacqueline M. Dekker, PhD; Giel Nijpels, MD, PhD; Robert J. Heine, MD, PhD; Otto Kamp, PhD;
Nico Westerhof, PhD; Lex M. Bouter, PhD; Coen D.A. Stehouwer, MD, PhD
Background—Type 2 diabetes (DM-2) and impaired glucose metabolism (IGM) are associated with an increased
cardiovascular disease risk. In nondiabetic individuals, increased arterial stiffness is an important cause of cardiovas-
cular disease. Associations between DM-2 and IGM and arterial stiffness have not been systematically investigated.
Methods and Results—In a population-based cohort (n747; 278 with normal glucose metabolism, 168 with IGM, and
301 with DM-2; mean age, 68.5 years), arterial stiffness was ultrasonically estimated by distensibility and compliance
of the carotid, femoral, and brachial arteries and by the carotid elastic modulus. After adjustment for age, sex, and mean
arterial pressure, DM-2 was associated with increased carotid, femoral, and brachial stiffness, whereas IGM was
associated only with increased femoral and brachial stiffness. Carotid but not femoral or brachial stiffness increased
from IGM to DM-2. Standardized s (95% CI) for IGM and DM-2, compared with normal glucose metabolism, were
0.06 (0.23 to 0.10) and0.37 (0.51 to0.23) for carotid distensibility;0.02 (0.18 to 0.18) and0.25 (0.40
to 0.09) for carotid compliance; 0.05 (0.23 to 0.13) and 0.25 (0.10 to 0.40) for carotid elastic modulus; 0.70
(0.89 to 0.51) and 0.67 (0.83 to 0.52) for femoral distensibility; and 0.62 (0.80 to 0.44) and 0.79
(0.94 to 0.63) for femoral compliance. The brachial artery followed a pattern similar to that of the femoral artery.
Increases in stiffness indices were explained by decreases in distension, increases in pulse pressure, an increase in
carotid intima-media thickness, and, for the femoral artery, a decrease in diameter. Hyperglycemia or hyperinsulinemia
explained only 30% of the arterial changes associated with glucose tolerance. Adjustment for conventional
cardiovascular risk factors did not affect these findings.
Conclusions—IGM and DM-2 are associated with increased arterial stiffness. An important part of the increased stiffness
occurs before the onset of DM-2 and is explained neither by conventional cardiovascular risk factors nor by
hyperglycemia or hyperinsulinemia. (Circulation. 2003;107:2089-2095.)
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Type 2 diabetes (DM-2) is associated with a markedincrease in risk of cardiovascular mortality.1 An in-
creased risk is already apparent in individuals with impaired
glucose metabolism (IGM), ie, impaired fasting glucose or
impaired glucose tolerance.2 The mechanisms responsible for
this increased cardiovascular disease risk remain unclear. In
nondiabetic individuals, increased arterial stiffness is an
important cause of cardiovascular disease, because arterial
stiffness leads to increased systolic pressure and ventricular
mass and to decreased diastolic coronary perfusion.3 There is
evidence that the metabolic alterations in DM-2 and IGM are
associated with increased arterial stiffness,4,5 but this has not
been systematically investigated.
Arterial stiffness is a general term that encompasses
properties such as distensibility, compliance, and elastic
modulus.6 Such properties are not uniform along the
arterial tree, and there may be important differences
between elastic and muscular arteries.7 Previous studies of
the association between DM-2 and arterial stiffness have
been relatively small5,8 –15 and were limited to one type of
artery4,9,11,12,14,15 or targeted selected populations,13,15
whereas data on the association between arterial stiffness
and IGM are scarce.4,13,16
In view of these considerations, we examined, in a
population-based cohort, associations between DM-2 and
IGM, and carotid, femoral, and brachial stiffness.
Received November 26, 2002; revision received February 7, 2003; accepted February 7, 2003.
From the Institute for Research in Extramural Medicine (R.M.A.H., P.J.K., A.M.W.S., J.M.D., G.N., R.J.H., L.M.B., C.D.A.S.); Institute for
Cardiovascular Research (R.M.A.H., A.M.W.S., O.K., N.W., C.D.A.S.); and Departments of Epidemiology and Biostatistics (P.J.K.), Physiology (N.W.),
Endocrinology (R.J.H.), and Internal Medicine (C.D.A.S.), VU University Medical Center, Amsterdam, the Netherlands.
Correspondence to Professor C.D.A. Stehouwer, MD, PhD; Department of Internal Medicine, VU University Medical Center, De Boelelaan 1117, 1081
HV Amsterdam, The Netherlands. E-mail cda.stehouwer@vumc.nl
© 2003 American Heart Association, Inc.
Circulation is available at http://www.circulationaha.org DOI: 10.1161/01.CIR.0000065222.34933.FC
2089
Clinical Investigation and Reports
 at Vrije on July 11, 2011http://circ.ahajournals.org/Downloaded from 
Methods
Study Population
For the present investigation, we used data from the 2000 Hoorn
Study follow-up examination and, to increase the number of indi-
viduals with DM-2, data from a diabetes screening study, both of
which were population-based.
The Hoorn Study is a cohort study of glucose metabolism in the
general population (n2484), which started in 1989.17 In 2000, a
follow-up examination was carried out among all surviving partici-
pants who had given their permission to be recontacted. We invited
all those who had diabetes, as determined by an oral glucose
tolerance test, or who were treated for diabetes at the previous 1996
follow-up (n176). Next, we invited random samples of individuals
with normal glucose metabolism (NGM) (n705) and IGM
(n193). Of 1074 individuals thus invited, 648 (60%) participated.
Additionally, we invited 217 individuals with DM-2 from the Hoorn
Screening Study,18 188 (87%) of whom participated.
All participants underwent a glucose tolerance test, except those
with previously diagnosed diabetes (n67). Data on 14 individuals
were missing because of logistical problems. Glucose tolerance was
defined according to the 1999 WHO criteria.19 The study population
(n822) thus consisted of 3 groups: 290 with NGM, 187 with IGM,
and 345 with DM-2.
Nonparticipants
Among the 455 nonparticipants (53% women), 13% were complete
nonresponders. The remaining nonparticipants gave the following
various reasons not to participate: lack of interest (30%), comorbid-
ity (23%), age (7%), unwillingness to travel (6%), participation too
time-consuming (6%), and miscellaneous reasons (15%).
Informed Consent
The local ethics committee approved the study. All participants gave
their written informed consent.
General Procedures
Blood Pressure Measurements
Brachial systolic and diastolic pressures were assessed in the left
upper arm at 5-minute intervals with an oscillometric device (Collin
Press-Mate, BP-8800). Brachial pulse pressure was calculated as
systolic minus diastolic pressure, and brachial mean arterial pressure
(MAP) as (2 diastolic pressuresystolic pressure)/3. Pulse pressure
at the carotid and femoral artery was calculated according to the
calibration method described by Kelly and Fitchett,20 with use of
distension waveforms as adapted by Van Bortel et al.21 This method
assumes a constant difference between MAP and diastolic pressure
(DP) along the arterial tree.7 Pulse pressure can then be calculated at
a target artery (PPtar) from the pulse pressure at a reference artery
(PPref) and a calibration factor (K) at target and reference arteries (Ktar
and Kref) by the formula:
PPtarPPref  Ktar/Kref,
in which K is defined as (MAPDP)/PP, and (MAPDP) can be
calculated from the area under the pressure curve divided by
time.20,21
As an alternative approximation of carotid pressures,22 aortic
pressures were derived by tonometry with a piezo-resistive pressure
transducer (SPT-301, Millar Instruments) connected to a waveform
analysis device (SphygmoCor, AtCor Medical). Briefly, after a left
brachial pressure reading, the transducer was used to applanate the
right radial artery. Pressure waveform data were then obtained
during 3 consecutive 12-second periods. A generalized transfer
function was then used to obtain the aortic waveform, which enabled
calculation of aortic pressures from the individual’s oscillometrically
derived pressure.22–24
Arterial Properties
Diameter, Distension, and Intima-Media Thickness
A single observer unaware of the participants’ clinical or glucose
tolerance status obtained properties of the right common carotid
(10 mm proximal to the carotid bulb), the right common femoral
(20 mm proximal to the flow divider), and the right brachial (20 mm
proximal to the antecubital fossa) arteries, with the use of an
ultrasound scanner equipped with an 7.5-MHz linear probe (350
Series, Pie Medical). The scanner was connected to a PC equipped
with vessel wall movement detection software and an acquisition
system (Wall Track System, Pie Medical). This setup enables
measurements of diameter, distension, and intima-media thickness
(IMT).25,26 Briefly, after a 15-minute supine rest, the artery was
visualized in B-mode. An M-line was then placed at the measure-
ment site. After switching to M-mode, data acquisition in a real-time
A-mode presentation on the computer screen was enabled after
trackball-assisted identification of the arterial lumen. Data were then
obtained during 3 consecutive 4-second measurements, triggered by
the R-top of a simultaneously recorded ECG. The first radiofre-
quency signal was displayed on the screen, enabling the observer to
check if the markers, positioned by the Wall Track System, coin-
cided with the anterior and posterior wall reflections in the diastolic
phase of the cardiac cycle. The cumulative radiofrequency signals
were then digitized and stored. The change in diameter as a function
of time (distension) was estimated and presented on the computer
screen (distension waveform). Diastolic diameter was calculated as
the difference in position between the anterior and posterior wall
markers. Additionally, the carotid posterior wall IMT was calculated
as the distance from the leading edge interface between lumen and
intima to the leading edge interface between media and adventitia.
The mean diameter, distension, and IMT of the 3 measurements were
used in the analyses.
Arterial Stiffness Distensibility, Compliance, and Young’s
Elastic Modulus
Distensibility and compliance coefficients were calculated from
diameter, distension, and pulse pressure, as follows27:
Distensibility coefficient(2D · DD2)/(P · D2) in 103 · kPa1
Compliance coefficient(2D · DD2)/(4 · P) in mm2 · kPa1,
where D is distension, D is diameter, and P is pulse pressure.
The distensibility coefficient reflects the arterial elastic properties,
whereas the compliance coefficient reflects the arterial buffering
capacity. From IMT, diameter, and carotid distensibility, we calcu-
lated Young’s elastic modulus (Einc), an indicator of the intrinsic
elastic wall properties:
Eincdiameter/(IMT distensibility coefficient) in kPa
Reproducibility
Reproducibility was assessed in 10 individuals (5 men; 58.29.5
years) who were examined twice, 2 weeks apart. The intraobserver
intersession coefficients of variation [CV(standard deviation of the
mean difference/2)/pooled mean] were as follows: carotid IMT,
10.9%; diameters, 2.9% (carotid), 2.5% (femoral), and 4.3% (bra-
chial); distension, 5.3% (carotid), 11.6% (femoral), and 12.8%
(brachial); distensibility coefficients, 7.0% (carotid), 11.3% (femo-
ral), and 12.8% (brachial); compliance coefficients, 6.3% (carotid),
13.1% (femoral), and 13.9% (brachial); carotid elastic modulus,
11.6%; and aortic pressures, 5.2% (systolic), 3.4% (diastolic), 3.8%
(pulse), and 3.2% (mean).
Other Measurements
Health status, medical history, current medication use, and smoking
habits were assessed by a questionnaire.17 Glucose, glycated hemo-
globin, serum total, high-density, and low-density-lipoprotein cho-
lesterol, and triglycerides were determined as described elsewhere.18
Resting electrocardiograms were automatically coded according to
the Minnesota Code,28 and body mass index and the waist-to-hip
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ratio were calculated. Hypertension and prior cardiovascular disease
were defined as described previously.18,28,29
Statistical Analysis
All analyses were carried out with SPSS (SPSS). We used multiple
linear regression analysis to investigate the associations between
glucose tolerance and arterial properties. All associations were first
analyzed without adjustments and then with adjustment for potential
confounders. Because arterial stiffness is affected by age, sex, and
MAP,7 these variables were considered first in the adjusted models.
We used brachial MAP for all adjustments, because MAP is constant
throughout the arterial tree7 and because brachial pressures were
determined more precisely (because of the greater number of
observations). After we had assessed the main effects, interaction
terms were used to investigate whether the association between
glucose tolerance and arterial properties differed according to age or
gender.27 P0.05 was considered statistically significant, except for
the interaction analyses, where we used P0.10.
Results
Ultrasound Examinations
Of the 822 participants, 18 did not take part in the ultrasound
examination for logistical reasons; in 8, data collection failed
for technical reasons. In the remaining 796 individuals,
qualitatively satisfactory examinations were obtained of 747
carotid, 689 brachial, and 665 femoral arteries. The main
reason for missing data was poor definition of the arterial wall
attributable to obesity (body mass index of those with
qualitatively satisfactory examinations versus those without,
26.93.3 versus 31.35.6 kg/m2, P0.001).
Baseline Characteristics
Table 1 shows the characteristics of the study population.
Arterial Properties
With deteriorating glucose tolerance, distension decreased,
diameter decreased (only in the femoral artery), pulse
pressure increased, and carotid IMT increased. As a result,
arterial stiffness, whether expressed as the distensibility
coefficient, the compliance coefficient, or as Young’s
elastic modulus, increased with deteriorating glucose tol-
erance (Table 2). Compared with NGM, DM-2 was signif-
icantly associated with increased carotid, femoral, and
brachial stiffness, whereas IGM was only significantly
associated with increased femoral and brachial stiffness
(Table 3). In general, these associations were partially
explained by MAP with a particularly strong effect for the
carotid stiffness indices in IGM (Table 3). When compared
with IGM, DM-2 was significantly associated only with an
increase of carotid stiffness.
Table 3 shows stiffness indices but does not provide
insight into which of the elements of the indices (disten-
sion, diameter, pulse pressure, or IMT) drives the changes.
Table 4 shows that the association between DM-2 and
increased stiffness was driven by a decrease in distension
(significantly so in the femoral and brachial arteries), a
decrease in diameter (in the femoral artery), an increase in
pulse pressure (all arteries), and, for elastic modulus, an
increase in carotid IMT. The association between IGM and
arterial stiffness was primarily driven by a decrease in
TABLE 1. Characteristics of the Study Population According to Glucose Tolerance
NGM IGM DM-2 P (trend)
No. (M/F) 278 (135/143) 168 (84/84) 301 (156/145)   
Age, y 68.76.1 70.36.3 67.38.1 0.185
Brachial systolic pressure, mm Hg 13720 14517 14920 0.001
Brachial diastolic pressure, mm Hg 759 789 809 0.001
Brachial mean arterial pressure, mm Hg 9512 10010 10311 0.001
Hypertension, % 56.1 72.7 82.2 0.001
Antihypertensive medication, % 25.6 39.0 51.1 0.001
Total cholesterol, mmol/L 5.791.03 5.801.03 5.551.05 0.005
HDL cholesterol, mmol/L 1.500.42 1.430.40 1.250.35 0.001
LDL cholesterol, mmol/L 3.690.90 3.690.93 3.480.90 0.003
Triglycerides, mmol/L 1.2 (0.9 to 1.5) 1.4 (1.0 to 1.8) 1.7 (1.2 to 2.3) 0.001
Lipid-lowering medication, % 13.1 16.6 19.3 0.039
Fasting glucose, mmol/L 5.430.37 6.070.48 7.701.75 0.001
Post-load glucose, mmol/L 5.631.15 8.011.69 11.662.87 0.001
Insulin, pmol/L 46.1 (35.2 to 59.7) 65.4 (48.9 to 88.2) 84.8 (56.3 to 116.8) 0.001
Glycated hemoglobin, % 5.690.41 5.880.39 6.620.93 0.001
Body mass index, kg/m2 26.23.3 27.94.1 29.35.0 0.001
Waist-to-hip ratio 0.900.09 0.940.08 0.960.10 0.001
Current smoking, % 15.2 17.1 13.6 0.537
(Micro-)albuminuria, % 10.3 15.0 20.5 0.001
Prior cardiovascular disease, % 42.5 47.8 55.7 0.001
Data are reported as meanSD or median (interquartile range).
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distension (significantly so in the femoral and brachial
arteries).
Additional Analyses
Interactions Between Glucose Tolerance and Age and Sex
The impact of deteriorating glucose tolerance on arterial stiffness
may be worse in women and with increasing age.4,30 Overall,
however, we found no such interactions, except that the associ-
ation of deteriorating glucose tolerance with brachial pulse
pressure was stronger in men (P0.04) and that, with femoral
artery, compliance was stronger in men (P0.002) and in
younger individuals (P0.001; data not shown).
Impact of Glucose and Insulin
To estimate the contribution of hyperglycemia and of hyper-
insulinemia to the increase in stiffness associated with IGM
and DM-2, we compared the above analyses with those
adjusted for HbA1c (or fasting or postload glucose) and for
insulin. This showed that at most one third of the arterial
changes associated with IGM and DM-2 could be explained
by hyperglycemia and hyperinsulinemia (data not shown).
Alternative Estimation of Carotid and Femoral Pulse Pressure
Results were qualitatively similar when we used brachial or
tonometry-derived instead of distension-waveform–calibrated
TABLE 2. Arterial Wall Properties According to Glucose Tolerance
NGM IGM DM-2 P (trend)
Carotid artery
Distension 352103 346114 338110 0.120
Diameter 7.801.15 8.041.14 8.090.99 0.001
Pulse pressure 5917 6214 6816 0.001
Intima-media thickness 0.830.16 0.870.16 0.880.16 0.001
Distensibility coefficient 12.824.34 11.564.55 10.444.25 0.001
Compliance coefficient 0.590.22 0.570.27 0.520.21 0.001
Young’s elastic modulus 0.870.44 0.940.43 1.100.65 0.001
Femoral artery
Distension 24373 17759 18366 0.001
Diameter 10.171.78 10.301.75 9.781.49 0.007
Pulse pressure 6817 7016 7418 0.001
Distensibility coefficient 5.732.25 3.971.66 4.071.82 0.001
Compliance coefficient 0.460.21 0.330.15 0.300.14 0.001
Brachial artery
Distension 16071 13867 13161 0.001
Diameter 4.560.73 4.660.71 4.770.73 0.001
Pulse pressure 6216 6714 6915 0.001
Distensibility coefficient 9.124.63 7.133.46 6.273.13 0.001
Compliance coefficient 0.150.07 0.120.06 0.110.06 0.001
Data are reported as meanSD. Distension is given in m; diameter and intima-media thickness
in mm; pulse pressure in mm Hg; distensibility in 103kPa1; compliance in mm2kPa1; and Young’s
elastic modulus in kPa. Carotid and femoral pulse pressure are those obtained by calibration (see
Methods).
TABLE 3. Stiffness Indices According to Glucose Tolerance: Adjusted Analyses
Carotid Artery Femoral Artery Brachial Artery
Model IGM DM-2 IGM DM-2 IGM DM-2
Distensibility coefficient
1: sexage 0.23 (0.41 to0.05)* 0.64 (0.78 to0.49)†‡ 0.79 (0.98 to0.60)† 0.83 (0.99 to0.68)† 0.49 (0.69 to0.29)† 0.72 (0.88 to0.56)†§
2: 1MAP 0.06 (0.23 to 0.10) 0.37 (0.51 to0.23)†‡ 0.70 (0.89 to0.51)† 0.67 (0.83 to0.52)† 0.40 (0.59 to0.20)† 0.56 (0.73 to0.40)†
Compliance coefficient
1: sexage 0.09 (0.27 to 0.10) 0.39 (0.54 to0.24)†‡ 0.67 (0.87 to0.51)† 0.92 (1.07 to0.77)†§ 0.38 (0.58 to0.18)† 0.49 (0.65 to0.33)†
2: 1MAP 0.02 (0.18 to 0.18) 0.25 (0.40 to0.09)†‡ 0.62 (0.80 to0.44)† 0.79 (0.94 to0.63)†  0.30 (0.50 to0.11)† 0.37 (0.54 to0.21)†
Young’s elastic modulus
1: sexage 0.09 (0.10 to 0.29) 0.50 (0.34 to 0.66)†‡            
2: 1MAP 0.05 (0.23 to 0.13) 0.25 (0.10 to 0.40)†‡            
Results are expressed as standardized  and 95% confidence intervals.
For absolute values, multiply standardized  by group SD.
*P0.025 vs NGM; †P0.005 vs NGM; ‡P0.005 vg IGM; §P0.025 vg IGM; 0.050 P0.100 vs IGM. Other P values 0.325. See Table 2 for units.
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pulse pressure. However, compared with distension-waveform–
calibrated pulse pressure, brachial pulse pressure overestimated
carotid and underestimated femoral stiffness, whereas
tonometry-derived pulse pressure overestimated carotid stiff-
ness. For example, the carotid distensibility coefficients in NGM
calculated with brachial, calibrated, or tonometric pressures were
11.90, 12.82, and 14.67 103 kPa1 (other data not shown).
Impact of Additional Adjustments
Results were similar when additionally adjusted for lipid
profile, use of lipid-lowering or antihypertensive medication,
body mass index, waist-to-hip ratio, smoking, (micro-) albu-
minuria, or prior cardiovascular disease (data not shown).
Discussion
This population-based study of glucose tolerance and arterial
stiffness had 4 main findings. First, after adjustment for age,
sex, and MAP, DM-2 was associated with increased arterial
stiffness of both elastic (carotid) and muscular (femoral and
brachial) arteries, whereas IGM was associated with in-
creased stiffness of the muscular arteries. Second, carotid but
not femoral or brachial stiffness increased from IGM to
DM-2, suggesting that an important part of the increased
stiffness occurs before the onset of DM-2. Third, increases in
stiffness indices were explained by decreases in distension,
increases in pulse pressure, an increase in carotid IMT, and,
for the femoral artery, a decrease in diameter. Fourth, indices
of hyperglycemia and hyperinsulinemia explained at most
one third of the arterial changes associated with IGM and
DM-2.
Our study was comprehensive and had important advan-
tages over previous investigations, which were relatively
small,5,8–12,14,31 concerned selected populations,13 and tar-
geted only 1 type of artery.4,8–12,14,31,32 None of these studies
determined how increases in arterial stiffness associated with
IGM and DM-2 were driven by changes in distension,
diameter, and pulse pressure. Additionally, our study is
among the first33 to estimate local pulse pressure by disten-
sion waveform calibration, which is more accurate than
brachial pulse pressure.21 Our data are in agreement with the
Atherosclerosis Risk In Communities (ARIC) study, which
also showed that DM-2 was associated with increased carotid
stiffness.4
We showed that both IGM and DM-2 were associated with
increased arterial stiffness (both decreased distensibility and
compliance) but that an important part of these changes
occurred before the onset of DM-2. Arterial stiffness is
thought to increase risk of cardiovascular disease through
several mechanisms.34 These findings may thus partially
explain why both IGM and DM-2 are associated with an
increased cardiovascular disease risk.
Decreased distension and increased pulse pressure contrib-
uted importantly to increased arterial stiffness. These changes
are thought to be related to quantitative and qualitative
alterations in arterial wall elastin and collagen.35 Our results
suggest that such alterations may be caused by factors other
than short-term hyperglycemia and hyperinsulinemia, such as
carbonyl and oxidative stress, chronic low-grade inflamma-
tion, and endothelial dysfunction,36 including that caused by
long-term hyperglycemia and formation of advanced glyca-
tion end products. Interestingly, Kass et al37 recently showed
that arterial stiffness in elderly, nondiabetic individuals could
be reduced by the use of a novel advanced glycation end
product crosslink breaker.
As glucose tolerance deteriorated, femoral diameter de-
creased but carotid and brachial diameter increased, indicat-
ing arterial remodeling, ie, the change of structural arterial
properties through time in response to alterations in the
arterial environment, in hemodynamics, or in vessel wall
material.38 Arterial remodeling is thought to keep tensile
stress and endothelial shear stress within certain limits of
operation38; it is not clear whether the preservation of arterial
compliance despite vessel wall stiffening is also a goal of
remodeling. From the viewpoint of arterial remodeling, the
increase in brachial and carotid diameter may serve to
decrease endothelial shear stress and preserve compliance;
the increase in carotid IMT could, at least partially, be viewed
TABLE 4. Individual Elements of the Arterial Stiffness Formulas and Their Association With Glucose Tolerance
Carotid Artery Femoral Artery Brachial Artery
Model IGM DM-2 IGM DM-2 IGM DM-2
Distension
1: sexage 0.02 (0.20 to 0.16) 0.18 (0.34 to0.03)*† 0.86 (1.05 to0.67)‡ 0.85 (1.00 to0.69)‡ 0.35 (0.55 to0.21)‡ 0.41 (0.58 to0.25)‡
2: 1MAP 1.0104 (0.19 to 0.18) 0.15 (0.32 to 0.01)†§ 0.86 (1.05 to0.69)‡ 0.85 (1.02 to0.69)‡ 0.33 (0.54 to0.13)‡ 0.40 (0.57 to0.22)‡
Diameter
1: sexage 0.16 (0.01 to 0.33) 0.31 (0.17 to 0.46)‡ 0.06 (0.14 to 0.25) 0.28 (0.44 to0.12)‡ 0.08 (0.09 to 0.25) 0.26 (0.12 to 0.41)†‡
2: 1MAP 0.05 (0.12 to 0.22) 0.14 (4.0103 to 0.29)§ 0.05 (0.15 to 0.25) 0.30 (0.47 to0.13)‡§ 0.05 (0.13 to 0.22) 0.20 (0.05 to 0.35)‡
Pulse pressure
1: sexage 0.17 (0.02 to 0.36)§ 0.57 (0.42 to 0.73)‡ 0.09 (0.01 to 0.29) 0.46 (0.30 to 0.62)‡ 0.22 (0.05 to 0.38)* 0.54 (0.40 to 0.68)‡§
2: 1MAP 0.04 (0.20 to 0.12) 0.23 (0.10 to 0.37)‡ 0.08 (0.24 to 0.09) 0.14 (2.0103 to 0.28)†§ 0.03 (0.16 to 0.10) 0.15 (0.04 to 0.27)‡
IMT
1: sexage 0.20 (0.02 to 0.38)* 0.38 (0.23 to 0.38)†‡            
2: 1MAP 0.17 (0.01 to 0.35)§ 0.32 (0.16 to 0.48)‡            
Results are expressed as standardized  and 95% confidence intervals.
For absolute values, multiply standardized  by group SD.
*P0.025 vs NGM; †0.050 P0.100 vs IGM; ‡P0.005 vs NGM; §0.050 P0.075 vs NGM; P0.005 vs IGM. Other P values 0.125. See Table 2 for units.
Henry et al Arterial Stiffness and Glucose Tolerance Status 2093
 at Vrije on July 11, 2011http://circ.ahajournals.org/Downloaded from 
as a compensatory response to counteract the increased wall
stress brought about by the diameter increase (Laplace’s law).
The decrease in femoral diameter may represent more ad-
vanced atherosclerosis, in which the initial compensatory
widening response ultimately fails and finally results in
arterial narrowing.39 The mechanisms through which diabetes
and IGM affect arterial remodeling are unknown and require
additional investigation.40
It is uncertain whether sex and age modify the relationship
between glucose tolerance and arterial stiffness.4,41 In our data,
the associations of glucose tolerance with femoral compliance
and brachial pulse pressure were stronger in men, whereas
associations with carotid stiffness indices were similar between
both sexes. In contrast, the ARIC study reported a stronger
association of glucose with carotid stiffness in women.4 How-
ever, this finding did not hold at a follow-up examination. We
found that the association of glucose tolerance and femoral
compliance decreased with increasing age but that associations
with other stiffness indices were not modified by age. This
contrasts somewhat with our earlier finding of a stronger
association between age and brachial pulse pressure in diabetic
compared with nondiabetic individuals.41 This could potentially
be explained by differences in composition of the study popu-
lation as well as by chance.
Our study had several limitations. First, our findings
were obtained in the elderly. Therefore, we may have
underestimated the association of arterial stiffness with
glucose tolerance because of selective mortality of indi-
viduals with diabetes and stiff arteries. Second, we used a
novel method to determine carotid IMT based on a single
point measurement technique.25 However, this method has
shown an excellent correlation with B-mode measure-
ments42; both are strongly related to age and blood
pressure,43 which was also the case in the present study
(data not shown). Additionally, we minimized measure-
ment variation related to IMT variability along the artery
by clearly defining where the measurements were taken.
Finally, data were obtained in a white population, and
therefore it remains to be established whether these results
can be generalized to other ethnicities. We conclude that
both IGM and DM-2 are associated with increased arterial
stiffness. An important part of the increased arterial
stiffness occurs before the onset of DM-2 and is not
explained by indices of hyperglycemia or hyperinsulin-
emia. These data provide a pathophysiological framework
for understanding why glucose tolerance is associated with
an increased risk of stiffness-related complications.
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